Demonstration of LanthaScreen™ TR-FRET-based nuclear receptor coactivator recruitment assay using PHERAstar, a multi-detection HTS microplate reader

Indian Journal of Pharmacology

Volumn 40, Issue 2, 2008, Pages 89-90

  D'Souza, Prashanth ^a   Ally, Nafisa ^b   Agarwal, Amit ^a   Rani, Padmaja ^a   Das, Meenakshi ^a   Sarma, Dolly ^a  

^a Natural Remedies Pvt Ltd   (India)

^b BMG LabTech Pty Ltd   (Australia)

Author keywords

HTS; LanthaScreen nuclear receptor coregulator assays; Nuclear receptors; PHERAstar; Time resolved fluorescence resonance energy transfer

Indexed keywords

ANTIBODY; CELL NUCLEUS RECEPTOR; DITHIOTHREITOL; GLUTATHIONE TRANSFERASE; LANTHANIDE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; TERBIUM; TRANSCRIPTION FACTOR;

ARTICLE; ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; MEASUREMENT; MOLECULAR INTERACTION; RECEPTOR BINDING; SCORING SYSTEM; TIME RESOLVED FLUORESCENCE RESONANCE ENERGY TRANSFER;

EID: 44949083404     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.41046     Document Type: Article

References (5)

1. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT. Nuclear receptor structure: Implications for function. Ann Rev Physiol 2007;69:201-20.
2. Hansen MK, Connolly TM. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr Opin Investig Drugs 2008;3:247-55.
3. Pearce KH, Iannone MA, Simmons CA, Gray JG. Discovery of novel nuclear receptor modulating ligands: An integral role for peptide interaction profiling. Drug Discov Today 2004;9:741-51.
4. Seethala R. Homogenous assays for high-throughput and ultrahigh-throughput screening. In: Seethala R, Fernandes PB, editors. Handbook of drug screening. New York: Dekker; 2001. p. 69-128.
5. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.